article

Formulation Development & Drug Delivery In-Depth Focus 2017

Posted: 22 February 2017 | | No comments yet

Understanding the effect of API changes in pharmaceutical processing; Improving the consistency of MDI drug delivery; and Expert Views with DDF Summit and Eurofins Lancaster Laboratories…

Formulation In-Depth Focus 2017
  • Understanding the effect of API changes in pharmaceutical processing
    John Gamble, John Jones and Mike Tobyn, Bristol-Myers Squibb
  • Improving the consistency of MDI drug delivery
    David Lewis, Chiesi Ltd
  • Expert View
    With DDF Summit
  • Expert View
    With Eurofins Lancaster Laboratories

This Formulation Development & Drug Delivery In-Depth Focus is restricted - login or subscribe free to access

european pharmaceutical review magazine cover issue 2 2018Thank you for visiting our website. To access this content in full you'll need to login. It's completely free to subscribe, and in less than a minute you can continue reading. If you've already subscribed, great - just login.

Why subscribe? Join our growing community of thousands of industry professionals and gain access to:

  • bi-monthly issues in print and/or digital format
  • case studies, whitepapers, webinars and industry-leading content
  • breaking news and features
  • our extensive online archive of thousands of articles and years of past issues
  • ...And it's all free!

Click here to Subscribe today Login here

 

Send this to a friend